SMMNY SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS
- 28.490
- +0.215+0.76%
SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS News
Siemens Healthineers AG Goes Ex Dividend Tomorrow
Siemens Healthcare joins hands with the CHESS Liver Health Alliance and the National Innovation Platform to jointly promote industry-university-research-medical innovation cooperation
The two sides plan to launch industry-university-research transformation cooperation in liver angiology technology and a team of academicians to jointly unveil the “Medical Engineering Cross-Innovation Workstation”. The scope of future cooperation will be further expanded to include the fields of accurate diagnosis and treatment of chronic liver disease, Hangzhou, April 15, 2024/PRNewswire/ -- Recently, empowered by Southeast University's National Medical Research, Obstetrics and Education Integration Innovation Platform, CHESS Liver Health Alliance and Siemens Healthcare will jointly unveil the “Medical Engineering Cross-Innovation Workstation”.” The “Medical Engineering Cross-Innovation Workstation” will be launched at Siemens Healthcare's Shanghai Innovation Center. The preliminary plans of the two sides revolve around the subject of chronic liver disease
Siemens Healthineers Commit to Increase Localization in China
Germany-based Siemens Healthineers pledged to deepen localization in China with an increasing number of localized products and the continuous localization of its supply chain as they have noticed the capability of independent innovation from the country, said the company's top executive for China.
Investing in Siemens Healthineers (ETR:SHL) Five Years Ago Would Have Delivered You a 57% Gain
SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS To Go Ex-Dividend On April 19th, 2024 With 0.51638 USD Dividend Per Share
March 27th - $SIEMENS HEALTHINEERS AG UNSPON ADR EACH REP 0.50 ORD SHS(SMMNY.US)$ is trading ex-dividend on April 19th, 2024. Shareholders of record on April 22nd, 2024 will receive 0.51638 USD di
Siemens Healthcare grew strongly in the first quarter, laying a solid foundation for the 2024 fiscal year
ERLANGEN, Germany, Feb. 1, 2024/PRNewswire/ -- Siemens Healthcare today released its results report for the first quarter of the 2024 fiscal year ending December 31, 2023. The equipment order shipment ratio in the first quarter of FY2024 was as high as 1.14, excluding the rapid COVID-19 antigen testing business, which was a strong increase of 7.0%; taking into account the rapid COVID-19 antigen testing business that had been terminated in the fourth quarter of FY2023, comparable revenue increased 5.7%, and the imaging business increased 5.3% compared to revenue; due to the adverse effects of the short-term business portfolio, adjusted profit before interest and tax
Siemens Healthineers Profit Rises on Revenue Growth
By Adria Calatayud Siemens Healthineers reported a rise in net profit for the first quarter of fiscal 2024, helped by higher sales driven by growth in its Varian radiation-oncology business. Net pro
GE HealthCare Falls as UBS Cut to Sell on Valuation
Siemens Healthcare confirms participation in the 7th China International Import Expo
SHANGHAI, November 8, 2023/PRNewswire/ -- On November 8, Siemens Healthcare signed a formal contract with the China International Import Expo Bureau to confirm participation in the 7th China International Import Expo. Liu Fuxue, Deputy Director of the China International Import Expo Bureau (second from left) and Siemens Healthcare Greater China President Wang Hao (second from right) attended and witnessed the signing ceremony
Siemens Healthcare performed strongly in the fourth quarter and ended fiscal year 2023 successfully
ERLANGEN, GERMANY, November 8, 2023/PRNewswire/ -- Siemens Healthcare recently released results reports for the fourth quarter of fiscal year 2023 and the full year of fiscal year 2023 and the full year of fiscal year 2023 ending September 30, 2023. FY2023: Revenue growth and earnings per share targets both reached equipment order delivery ratio of 1.15 Excluding the rapid COVID-19 antigen testing business, comparable revenue increased significantly by 8.3%; the rapid COVID-19 antigen testing business was terminated in the fourth quarter. Including this business, comparable revenue increased by 1.2%, and Varian Healthcare's comparable revenue grew strongly by 14.8 percent
Sun Yat-sen Memorial Hospital of Sun Yat-sen University and Siemens Healthcare signed a strategic cooperation agreement at the 6th CIIE
SHANGHAI, November 6, 2023/PRNewswire/ -- Today, at the Siemens Medical booth at the 6th CIIE, Sun Yat-sen Memorial Hospital of Sun Yat-sen University and Siemens Healthcare China signed a strategic cooperation agreement. The two sides will jointly explore the scientific research application and medical transformation of metaverse visual surgery in frontal lateral flap transplantation. Director Fan Song of Oral and Maxillofacial Surgery at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and Wang Chao, Vice President of Siemens Healthcare Greater China, attended the signing ceremony. According to the agreement, Siemens Healthcare will collaborate with Sun Yat-sen Memorial Hospital to develop a positioning and registration tool for anterolateral flap transplantation to achieve metaverse visualization of stocks
Siemens Healthcare exhibited the world's first four-dimensional volumetric intracardiac ultrasound catheter at the 6th Expo
SHANGHAI, November 6, 2023/PRNewswire/ -- At the 6th Expo, Siemens Healthcare exhibited the world's first four-dimensional volumetric intracardiac ultrasound catheter, ACUSON AcuNav Volume [1] (hereinafter referred to as the “four-dimensional ICE catheter”). This ultrasound catheter is a pioneering innovative device in the field of structural heart disease, pioneering changes in surgical procedures for ultrasound in structural heart disease. Siemens Healthcare's four-dimensional volumetric intracardiac ultrasound catheter Today, the world is facing an aging population trend. Various arrhythmic diseases such as valvular heart disease and atrial fibrillation have become important threats to people's health
China Intl Expo Showcases New Cutting Edge Medical Technology
The China International Import Expo, which opened on Sunday, has proven to be a premier platform for companies from around the world to showcase their latest cutting-edge products as proven by the slew of exhibits making their global or regional debut.
Siemens Healthcare brought a variety of major new products to participate in the Expo event for the sixth time
SHANGHAI, November 4, 2023/PRNewswire/ -- Recently, Siemens Healthcare, the world's leading medical technology company, participated in the China International Import Expo (hereinafter referred to as the “Expo”) for the sixth time under the theme of “Innovation World, for Every Life”. As a “fan” who has never been absent, Siemens Healthcare will present a panoramic view of more than 20 cutting-edge innovative medical technologies and solutions in the “Medical Devices and Healthcare Exhibition Area” this year. Tao Lin, a member of the board of directors of Siemens Healthcare, said, “The Expo is an important initiative for China to promote a high level of opening-up to the outside world in the new era. It is also the end for enterprises to showcase their innovative strength and broaden development opportunities
Siemens Healthineers Said to Be Evaluating Options for Diagnostics Unit
Siemens X-Ray Vacuum Technology (Wuxi) Co., Ltd. celebrated its 20th anniversary
Leading multinational enterprises, as early as 20 years ago, it established a core X-ray tube production base in Wuxi, China. Siemens Medical's only X-ray tube component R&D and production base outside of its German headquarters achieved a leap forward in R&D and manufacturing capabilities, injecting new momentum into the development of local medical imaging to improve the local supply chain, driving the supply chain ecosystem to focus more on the development and production of high-end tube products in the future, Wuxi October 17, 2023 /PRNewswire/ -- Today, Siemens X-Ray Vacuum Technology (Wuxi) Co., Ltd. (hereinafter referred to as “Wuxi”). “20. Follow the light and go far” is the main focus
These Companies Set to Benefit From Sales of Biogen Alzheimer's Med Leqembi
Global Cardiac Marker Analyzer Market Research Report 2022-2023 & 2028: Critical Role of Cardiac Biomarkers in the Fight Against Heart Disease but Regulatory Challenges Could Hinder Growth
DUBLIN, Sept. 19, 2023 /PRNewswire/ -- The "Global Cardiac Marker Analyzer Market and Forecast, Impact of COVID-19, Product Analysis, Companies Business & Marketing Strategy, Major Deals" report has been added to ResearchAndMarkets.com's offering.
Siemens Healthcare expands production site in Rudolstadt, Germany to produce core components for Walian radiotherapy equipment
A radiotherapy equipment parts manufacturing plant will be built, and the new plant is expected to be officially put into operation in mid-2024, with an investment of about 25 million euros, demonstrating its firm commitment to the Rudolstadt plant Erlangen September 7, 2023 /PRNewswire/ -- Recently, Siemens Healthcare announced the expansion of its production site in Rudolstadt (Rudolstadt), Germany. By mid-2024, a new production building will be built at the site. The new production building will produce the electron accelerators required for radiation sources for Siemens Medical's Varian cancer radiotherapy equipment. The building will also be expanded with a liquid metal sliding shaft
Siemens Healthcare maintained strong revenue momentum in the third quarter
Erlangen, Germany, August 3, 2023 /PRNewswire/ -- Siemens Healthcare recently released its quarterly report for the third quarter of fiscal year 2023 from April 1, 2023 to June 30, 2023. Total equipment orders in the third quarter of FY2023 clearly surpassed the strong growth of total equipment revenue; equipment order shipments reached 1.11 excluding rapid COVID-19 antigen testing business, which was a strong 10.1% increase in comparable revenue; taking into account this shrinking demand business, comparable revenue increased 3.6%, and the video business had a comparable revenue increase of 15.2%, and the adjusted profit margin before interest and tax compared to the previous year
Analysis
Price Target
No Data
